A stimulation study linked improvements in executive-function ratings with improvements in craving. Because the analyses used change during treatment, they did not establish a ready-to-use pretreatment test for selecting who should receive stimulation.
Wang and colleagues compared methamphetamine-use-disorder patients with healthy adults and randomized patients to intermittent theta-burst stimulation or sham. Executive functioning was assessed with the BRIEF-A questionnaire and craving with visual analogue ratings. The clinical sample included 66 men; selected treatment-response analyses used a smaller active-treatment subgroup.
Reduced executive-function problem scores, particularly working-memory and global ratings, were associated with craving reduction. The investigators also constructed receiver-operating-characteristic analyses using reduction rates to classify response. Such a model describes how observed changes align with an outcome in the available data. It is different from predicting future response using only information available before treatment starts. The inhibition reduction-rate classification was not statistically significant.
One executive-function rating scale does not represent a comprehensive objective cognitive battery. The all-male institutional sample and small modeling subgroup limit precision and generalization. A cutoff selected in the development sample needs independent validation before clinical use, and correlated questionnaire changes do not prove causal mediation. The outcome was craving-related response rather than established long-term abstinence. The study supports further work on monitoring treatment, while selection of therapy, mechanistic explanation and relapse prediction remain separate questions requiring evidence designed for each purpose.
See why a self-reported executive outcome should be named explicitly.